Phospholamban physically interacts with the sarcoplasmic reticulum calcium pump (SERCA) and regulates contractility of the heart in response to adrenergic stimuli. We studied this interaction using electron microscopy of 2D crystals of SERCA in complex with phospholamban. In earlier studies, phospholamban oligomers were found interspersed between SERCA dimer ribbons and a 3D model was constructed to show interactions with SERCA. In this study, we examined the oligomeric state of phospholamban and the effects of phosphorylation and mutation of phospholamban on the interaction with SERCA in the 2D crystals. On the basis of projection maps from negatively stained and frozen-hydrated crystals, phosphorylation of Ser16 selectively disordered the cytoplasmic domain of wild type phospholamban. This was not the case for a pentameric gain-of-function mutant (Lys27Ala), which retained inhibitory activity and remained ordered in the phosphorylated state. A partial loss-of-function mutation that altered the charge state of phospholamban (Arg14Ala) retained an ordered state, while a complete loss-of-function mutation (Asn34Ala) was also disordered. The functional state of phospholamban was correlated with an order-to-disorder transition of the phospholamban cytoplasmic domain in the 2D co-crystals. Furthermore, co-crystals of the gain-of-function mutant (Lys27Ala) facilitated data collection from frozen-hydrated crystals. An improved projection map was calculated to a resolution of 8 Å, which supports the pentamer as the oligomeric state of phospholamban in the crystals. The 2D co-crystals with SERCA require a functional pentameric form of phospholamban, which physically interacts with SERCA at an accessory site distinct from that used by the phospholamban monomer for the inhibitory association.
Introduction
Cation transport by the P-type ion pumps is an essential process in all eukaryotic cells, where changes in intracellular cation concentrations are linked to precise physiological responses. The best understood members of this transport family include *Corresponding author. E-mail address: hyoung@ualberta.ca.
Abbreviations used: SERCA, sarcoplasmic reticulum calcium ATPase; SR, sarcoplasmic reticulum; PLB, phospholamban; PKA, cAMP-dependent protein kinase. the sarcoplasmic reticulum calcium ATPase (SERCA) found in muscle cells and the plasma membrane sodium-potassium ATPase (Na + -K + pump) found in all cell types. These two P-type ion pumps are particularly important in cardiac contractility and are major drug targets for the clinical improvement of heart disease. An extensive series of X-ray and electron crystallographic studies have resulted in structures of a variety of SERCA reaction intermediates, thus revealing how ATP hydrolysis is coupled to calcium transport across the sarcoplasmic recticulum (SR) membrane in order to achieve muscle relaxation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] These studies show that SERCA is composed of a transmembrane domain that contains the calcium-binding sites and three cytosolic domains that are responsible for nucleotide binding, phosphorylation, and communication with the transmembrane domain. It has been shown that the intermediate states (calcium binding, phosphorylation, calcium transport, dephosphorylation and proton counter-transport) involve coupled domain movements that link the cation-binding sites with the phosphorylation state of the enzyme.
Despite this wealth of structural information, the regulation of the calcium pump in cardiac muscle remains an elusive target of study. In cardiac and smooth muscle, SERCA is regulated by phospholamban (PLB), a 52 residue integral membrane protein. PLB engages in an inhibitory interaction with SERCA that reduces its apparent calcium affinity. This is a dynamic process that depends on the cytosolic calcium concentration, as well as the phosphorylation and oligomeric states of PLB, which is in dynamic equilibrium between monomeric and homo-oligomeric states, with pentameric forms being dominant in SDS-PAGE. 15, 16 Mutation of key leucine and isoleucine residues in the transmembrane domain of PLB destabilizes the pentameric structure and has been shown to shift this equilibrium in favor of the monomer. These pentamer-disrupting mutations are associated with increased inhibition of SERCA, leading to the speculation that the PLB monomer is the active inhibitory species, [17] [18] [19] and that the pentamer is an inactive storage form. 20, 21 Unfortunately, it has not been possible to test this model directly with well defined PLB oligomeric states within a lipid membrane. In any case, SERCA inhibition by the PLB monomer can be reversed either by elevated cytoplasmic calcium concentrations or by phosphorylation of PLB. The primary physiological mechanism for relieving SERCA inhibition is through the phosphorylation of PLB at Ser16 by cAMPdependent protein kinase (PKA), and PLB can be phosphorylated at Thr17 by either calcium/calmodulin-dependent protein kinase II 22 or by Akt. 23 The functional effect of PLB phosphorylation on SERCA regulation is clear but the mechanism for this effect is less certain. The original model for SERCA regulation suggested that monomeric PLB binds to and inhibits SERCA, and phosphorylation disrupts this inhibitory complex. 24, 25 However, there is contradictory evidence about whether PLB is physically dissociated from SERCA following phosphorylation. Fluorescence energy transfer experiments suggest that PLB inhibits and aggregates SERCA, and that phosphorylation reverses this process and causes dissociation of PLB and SERCA. 26 Similarly, cross-linking experiments indicate that phosphorylation weakens the physical association of PLB with SERCA and makes the complex more susceptible to dissociation by sub-saturating concentrations of calcium. 27, 28 In contrast, studies using co-immunoprecipitation, 29 fluorescence 30, 31 and EPR spectroscopy 32 all suggest that PLB remains associated with SERCA following phosphorylation. Rather than dissociation of PLB from SERCA after phosphorylation, EPR and NMR studies point to a transition from order to disorder in the cytoplasmic domain of PLB. 32, 33 Such a transition is consistent with the results of a variety of biophysical studies showing that phosphorylation causes a partial unwinding and disordering of the PLB N-terminal α-helix around the Ser16 phosphorylation site. [34] [35] [36] [37] [38] Regulation by phosphorylation is thought to occur in the context of a complex between monomeric PLB and SERCA yet it has been suggested that the PLB pentamer is necessary for regulation of cardiac contractility in a physiological context; 39 and a direct interaction has been proposed between the PLB pentamer and SERCA. [40] [41] [42] EPR measurements of boundary lipids suggest that phosphorylation of PLB shifts the population towards the oligomeric state. 16 These results raise questions about the role of PLB oligomeric states in the regulation of SERCA.
In earlier work, we observed a direct interaction between an oligomeric form of PLB and SERCA in 2D crystals. 42 Specifically, we characterized co-crystals of SERCA and a super-inhibitory mutant of PLB (Ile40Ala; I40A). 42 While SDS-PAGE indicated that this mutant of PLB was monomeric, 17 our projection map revealed that I40A formed an oligomer, which was later supported by fluorescence resonance energy transfer experiments. 43, 44 These results reinforce the conclusion reached by Jones and co-workers, that SDS-PAGE might indicate the relative stability of PLB oligomers but it is not a definitive means of assessing the oligomeric species adopted by PLB within the lipid bilayer. 18 A 3D model based on our projection map suggested that PLB pentamers interact with SERCA at two potential sites; one near transmembrane segment M3 and another near the C-terminus. These contact sites are distinct from the inhibitory site occupied by the PLB monomer, which is adjacent to M2, M4 and M6 of SERCA according to the results of mutagenesis and cross-linking studies. [45] [46] [47] [48] [49] In this study, we investigated the effects of PLB phosphorylation and mutation on the interaction between a PLB oligomer and SERCA in the context of 2D crystals. Our results show a correlation between PLB function and crystal formation, suggesting that the physical interactions that stabilize the crystal are sensitive to physiologically relevant perturbations. Our data are consistent with an order-to-disorder transition in the PLB cytoplasmic domain, where the inhibitory forms of PLB (e.g. wild type and the gain-of-function mutant Lys27Ala) retain an ordered state in the crystals and the non-inhibitory forms of PLB (phosphorylated wild type and a loss-of-function mutant Asn34Ala) adopt a disordered state.
Results
Co-reconstitution of SERCA and PLB Methods for co-reconstituting SERCA and PLB have been established for both functional 50, 51 and structural studies. 42, 52, 53 Co-reconstituted proteoliposomes have been shown to have a lipid/protein molar ratio of approximately 120:1 and a PLB/ SERCA molar ratio of 3.5:1.
42,51 These conditions mimic cardiac SR and, under the appropriate buffer conditions, they promote formation of 2D crystals. Measurements of ATPase activity have been used to demonstrate the regulatory interactions between wild type and mutants forms of PLB and SERCA. For the current studies, wild-type PLB, a gainof-function mutant (Lys27Ala), a partial loss-offunction mutant (Arg14Ala), and a complete loss-offunction mutant (Asn34Ala) were chosen to represent different functional forms of PLB. 17, 19, 51, [53] [54] [55] Importantly, the oligomeric stability of the mutants used for 2D crystallization was similar to that of wild type PLB, despite differences in their ability to regulate SERCA. 17, 55 Measurements of ATPase activity were used to determine the apparent calcium affinity of SERCA in the absence and in the presence of PLB (Table 1) . Reconstituted SERCA in the absence of PLB had a K Ca value of 0.41 ± 0.01 μM calcium, and co-reconstituted SERCA in the presence of wild-type PLB had a K Ca value of 0.69 ± 0.01 μM calcium. The K Ca values (μM calcium) in the presence of mutant forms of PLB were 1.00 ± 0.03 for K27A, 0.59 ± 0.03 for R14A and 0.46 ± 0.03 for N34A.
We tested the effect of PKA phosphorylation on the inhibitory capacity of PLB. After co-reconstitution, phosphorylation of wild type PLB restored the apparent calcium affinity of SERCA to control levels ( Fig. 1a ; Table 1 ). However, phosphorylation of the K27A mutant by PKA did not completely restore the apparent calcium affinity of SERCA ( Fig. 2a ; Table  1 ). The K Ca values in the presence of phosphorylated forms of PLB were 0.43 ± 0.02 μM calcium for wild type (nearly complete (93%) reversal of inhibition) and 0.65 ± 0.03 μM calcium for K27A (partial (59%) reversal of inhibition). Both SDS-PAGE (Figs 1b and   2b ) and matrix-associated laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF; data not shown) were used to demonstrate stoichiometric phosphorylation of wild type and K27A PLB. The R14A and the N34A mutants were not treated with PKA because the former is not recognized by PKA 56 and the latter (loss-of-function) is not affected by phosphorylation. Finally, our observation that phosphorylated K27A remains partially inhibitory (Fig.  2a) is consistent with earlier work demonstrating that phosphorylated N27C also retains its inhibitory capacity and can be cross-linked to SERCA. 28 Note that residue 27 is lysine in the human protein (used here) and asparagine in the canine protein. 28 Co-crystallization of SERCA and PLB We next tested the ability of wild type, mutant and phosphorylated forms of PLB to interact with SERCA in large 2D co-crystals. 42 The proteoliposomes described above were capable of forming crystals after treatment with decavanadate, EGTA, and a freeze-thaw procedure designed to enhance proteoliposome fusion and crystal growth. However, the PLB mutants varied markedly in their ability to form co-crystals. In order to characterize the effect of mutation and phosphorylation on crystal formation, care was taken to ensure that the crystallization conditions were equivalent between the various samples. The number of crystals in a grid square (2500 μm 2 ) was counted in negatively stained samples ( Table 2 ). Wild type PLB produced a moderate frequency of about three crystals in a grid square and other samples revealed a correlation between the functional state of PLB and its propensity to form co-crystals with SERCA. For example, the K27A gain-of-function mutant formed about five crystals in a grid square, and the N34A loss-offunction mutant formed about one crystal in a grid square. This analysis was not done for the R14A mutant. Despite changes in crystal frequency and order, the crystal morphology and lattice parameters were similar to one another and to those reported earlier. 42 In particular, all crystals exhibited p22 1 2 1 plane group symmetry with approximate lattice dimensions of a = 345 Å and b = 70 Å (γ = 90°).
Projection maps from negatively stained 2D co-crystals
For each form of PLB, projection maps of negatively stained samples were calculated after averaging Fourier data from five different crystal images at a resolution of~20 Å. To rule out differences in negative staining, two or three projection maps were calculated for each form of PLB, where each map represented an independent co-reconstitution, crystallization and negative stain EM grid. Typical projection maps are shown for non-phosphorylated and phosphorylated wild type PLB (Fig. 1) . Consistent with what was observed earlier, 42 the projection maps were dominated by rows of 2-fold related densities that corresponded to anti-parallel dimer arrays of SERCA. In the presence of wild type PLB, additional density was interspersed between the SERCA arrays, consistent with the presence of PLB oligomers (Fig. 1c) . These patches of extra density were relatively small in the maps of negatively stained crystals, owing to the low contrast generated by negative stain within the lipid bilayer and the small size of the cytoplasmic domain of PLB relative to SERCA. Nonetheless, the PLB density in the projection maps was similar to those reported earlier. 42 Upon phosphorylation of Ser16 with PKA, the PLB density was no longer present, consistent with disordering of the cytoplasmic domain (Fig. 1d) . As mentioned above, phosphorylation of wild type PLB also reduced the frequency of co-crystal formation (Table 2) .
We studied the effect of phosphorylation on the co-crystals with K27A PLB, which has the same oligomeric state as wild type PLB. 17, 55 Like wild type PLB, the projection maps of non-phosphorylated K27A co-crystals show PLB density lying between the anti-parallel dimer ribbons of SERCA (Fig. 2) . The frequency of the K27A co-crystals is higher than that of the wild type, reflecting the fact that the K27A mutation produces a super-inhibitory PLB molecule (gain of function). Interestingly, phosphorylation of K27A had no effect on the PLB density (compare Figs. 1d and 2d ). This behavior is consistent with the fact that stoichiometric phosphorylation of K27A is unable to fully reverse its inhibition of SERCA ( Fig. 2a and b) . We reasoned that if phosphorylation disrupted a crystal contact or altered contrast produced by negative stain (e.g., by adding a negative charge to the cytoplasmic domain), then phosphorylation of K27A co-crystals should produce a result similar to the wild type PLB (Fig. 1c and d) . However, if co-crystallization relies on a functional interaction between PLB and SERCA, then the inhibitory properties of the phosphorylated K27A mutant should correlate with its behavior during co-crystallization. Based on our observations, we believe that the cytoplasmic domain of wild type PLB becomes disordered upon phosphorylation, whereas the cytoplasmic domain of K27A does not. This comparison rules out the possibility that the disappearance of the PLB density was a result of simply adding the negative charge (PO 4 2-) to its cytoplasmic domain.
Additional mutants of PLB
Since the phosphorylation of wild type PLB reverses SERCA inhibition and alters density in the 2D co-crystals, we tested the effects of (i) mutation of a charged residue (Arg14) proximal to the phosphorylation site (Ser16) and (ii) a well-characterized loss-offunction mutant (N34A). As reported earlier, 17, 56 R14A retains substantial inhibitory capacity (Fig. 3a) , whereas N34A is a complete loss-of-function mutant (Fig. 4a) . The R14A mutant changes the net charge of the PLB cytoplasmic domain adjacent to the phosphorylated residue Ser16, while the N34A mutant is located at the interface between the membrane and the cytosol. In projection maps of negatively stained co-crystals with R14A PLB, additional density was observed between the rows of SERCA molecules (Fig. 3b) . However, in co-crystals with N34A PLB, the additional density was absent (Fig. 4b) . These results further support the idea that the functional state, rather than the net charge of the cytoplasmic domain, determines the stability of co-crystals and whether PLB-associated densities are visible in the projection maps. Interestingly, the N34A mutation appears to cause a disordering of the cytoplasmic domain that is similar to the effect of phosphorylation of the wild type PLB.
Projection maps from frozen-hydrated 2D co-crystals
Our observations of negatively stained crystals indicated that the co-crystallization of PLB and SERCA was negatively impacted by PLB phosphorylation and that the cytoplasmic domain of PLB tended to become disordered. To test if this disordering affected the transmembrane domain of PLB, we imaged the co-crystals in the frozenhydrated, unstained state. Based on molecular models for PLB, 41, 57, 58 the density associated with PLB in projection maps from frozen-hydrated cocrystals is dominated by the pentameric transmembrane coiled coil. This is due to the alignment of the transmembrane helices along the imaging direction, which produces very strong density in the corresponding projection maps. Therefore, comparison of the density observed in negatively stained co-crystals with that observed in frozen-hydrated crystals allows us to evaluate the relative ordering of the cytoplasmic and transmembrane domains, respectively. In particular, if phosphorylation disorders primarily the cytoplasmic domain of PLB as predicted, 32 density attributable to PLB should be weak in the negatively stained samples and unaffected in frozen-hydrated samples. For this comparison, projection maps were calculated from images of frozen-hydrated co-crystals with wild type PLB before and after PKA phosphorylation. Following merging and averaging of data from at least five crystal images, diffraction amplitudes with high signal-to-noise ratios and low phase residuals were observed for all resolution shells to a resolution of 10 Å ( Table 3 ). The resulting maps were nearly identical, both containing anti-parallel dimer ribbons of SERCA molecules interspersed with density consistent with pentameric PLB (Fig. 5) . This similarity suggests that intramembrane interactions between SERCA and the transmembrane domain of PLB mediate contacts in the crystals and that these contacts persist after phosphorylation of the PLB cytoplasmic domain. Loss of density for these cytoplasmic domains suggests that they are disordered and thus not strongly bound to SERCA after phosphorylation. Given the negative effect of phosphorylation on crystal order, the PLB cytoplasmic domain probably provides additional interactions in the non-phosphorylated state.
What is the oligomeric state of PLB in the co-crystals?
To further characterize the physical interaction between SERCA and PLB and to evaluate its oligomeric state in the co-crystals, we used frozenhydrated preparations to improve the resolution of the existing projection map. 42 We chose to image cocrystals of K27A PLB because the relative abundance and high quality of these crystals facilitated data collection. Images from frozen-hydrated cocrystals displayed computed diffraction to a resolution of approximately 15 Å. Following merging and averaging of data from 15 crystal images, diffraction amplitudes with high signal-to-noise ratios and low phase residuals were observed for all resolution shells to a resolution of 8 Å ( Fig. 6 ; Table 3 ).
The resulting projection map for SERCA in the presence of K27A PLB is similar to that determined for SERCA in the presence of I40A PLB. 42 The size and shape of the additional densities seen in our projection maps were consistent with the pentamer, which is the principle oligomeric form of PLB observed by SDS-PAGE. However, neither map from frozen-hydrated co-crystals (I40A reported earlier 42 or K27A reported here) provided direct evidence of pentameric assembly of PLB, presumably due to limited resolution. To address this issue, the high-resolution terms of the projection map were enhanced by applying a negative B-factor (temperature factor) of 500 Å -2 . 59 The truncation of Fourier data at 8 Å resolution ensured that the contribution of noise in our map was minimal. This procedure improved contrast and detail for the densities associated with both SERCA and PLB (Fig. 7) . Significantly, the density assigned to the PLB oligomer resolved into a five-lobed density consistent with the PLB pentamer. However, rather than the symmetric structure predicted by NMR structural models, 41, 58 our density resembles a distorted pentamer (Fig. 7b-d) , where two of the five observed lobes are stronger and better delineated than the others. Although the shape of the pentamer might be affected by the increased noise in the "sharpened" projection map, a physical distortion of the pentamer would be consistent with its asymmetric interaction with SERCA. Interestingly, the stronger densities in the pentamer are proximal to SERCA, and one appears next to transmembrane segment M3 (asterisk in Fig. 7a ). An interaction between M3 of SERCA and PLB was also suggested by our earlier studies of the complex using electron cryo-microscopy of helical crystals (Fig. 4 in 53) .
Discussion Physical interactions between SERCA and PLB
There is general consensus that the monomeric form of PLB interacts with M2, M4 and M6 of SERCA, 17, 19, 20, 25, 48, 49 producing the inhibition that characterizes the resting state of cardiac muscle. However, oligomeric forms of PLB have been observed repeatedly both in detergent and membranous environments. While the pentamer appears to be the most stable oligomer, tetramers, trimers and dimers have all been observed and the balance between them can be influenced by single-site mutations. 17, 19 Furthermore, there is dynamic exchange between oligomeric and monomeric forms of PLB and evidence that phosphorylation of PLB or increased cytosolic calcium concentrations increase the proportion of the pentameric pool at the expense of the monomeric pool. 16 This evidence has led to the hypothesis that the monomer represents the "active" inhibitory form and that oligomeric forms represent an inactive reserve. 20, 21 While several congruent molecular models explaining the inhibitory properties of PLB are described in the literature, 47, 48, 60, 61 there are a number of inconsistencies in published observations that are not fully explained. First, Kranias and colleagues demonstrated that a mutant form of PLB (Cys41Phe) was insufficient for proper regulation of cardiac contractility in a mouse model. 39 Because this mutant was reported to be monomeric with the same inhibitory potency as the wild type protein, 62 the authors inferred a physiological role for the PLB pentamer. Despite the fact that the oligomeric state of the C41F mutant has not been demonstrated directly in a membranous environment, this notion is consistent with independent observations that SERCA might interact with oligomeric forms of PLB. [40] [41] [42] 63 Thus, the existence of oligomers appears to offer a functional advantage for the SERCA-PLB interaction, 40 and this advantage is not explained by current molecular models (i.e., PLB oligomers as inactive storage forms). Second, there are disparate observations on how the physical association between SERCA and PLB responds to phosphorylation. One group of studies postulate that PLB remains associated with SERCA and phosphorylation alters the structural interaction between the two proteins, 29, [30] [31] [32] 64 whereas contradictory crosslinking studies have led to the notion that intermolecular interactions at the M2, M4 and M6 interface are lost following phosphorylation 27, 28 and PLB dissociates from SERCA.
More specifically, chemical crosslinking experiments indicated that PKA-mediated phosphorylation decreases the efficiency of crosslinking to SERCA at multiple sites distributed throughout both the cytoplasmic and the transmembrane domains of PLB. 27, 28 The inference then is that phosphorylation decreases binding affinity of PLB for SERCA and causes it to dissociate at sub-saturating concentrations of calcium. Contradictory evidence in favor of persistent association comes from the following literature. Antibodies recognizing PLB phosphorylated at Ser16 were shown to coimmunoprecipitate SERCA1a and SERCA2a after co-expression in HEK-293 cells. 29 Fluorescence, spinlabel EPR spectroscopy and other biophysical studies demonstrated that SERCA restricts the motional freedom of PLB both before and after phosphorylation. 30, 31 More recent EPR studies also support persistent association and suggest that phosphorylation induces a dynamically disordered state in the PLB cytoplasmic domain and supported the idea that phosphorylated PLB remains associated with SERCA in a non-inhibitory state. 32 Despite this growing body of evidence, it is difficult to envision how PLB might remain bound to the M2, M4 and M6 interface of SERCA, given the large conformational changes caused by calcium binding that occlude this interaction interface.
These apparent contradictions can be reconciled by hypothesizing a physical interaction between SERCA and oligomeric PLB at a secondary, noninhibitory site. Specifically, we have observed an interaction between M3 of SERCA and the PLB pentamer in the 2D co-crystals. Such an interaction could explain the mutual effects that SERCA and PLB have on spectroscopic analysis of each other's aggregation state 42, 63 and could provide a direct role for the PLB oligomer under physiological conditions. 39 In addition, distinct functional consequences and binding sites of the monomer and oligomer could explain the experimental discrepancy regarding the persistence of the interaction. The PLB monomer might dissociate from the M2, M4 and M6 inhibitory site under the appropriate physiological stimuli and there could be a high probability for interaction with the PLB oligomer at the secondary site on the other side of the SERCA molecule (e.g., M3). Compared to the dramatic movements of M2, M4 and M6 during calcium binding, the transmembrane helix M3 of SERCA is less mobile and might represent a stable interaction point for a PLB oligomer that is insensitive to phosphorylation or the level of cytosolic calcium.
In the present work, our data support a functionally relevant interaction between SERCA and a PLB oligomer in 2D co-crystals. In particular, the effects of PLB mutants on crystallization are correlated with their effects on the inhibition of SERCA. The K27A and N34A mutations were chosen for the similar stability of their pentameric form, yet widely different inhibitory behavior. Thus, it is significant that the gain-of-function K27A mutation enhanced crystallization, whereas the loss-of-function N34A mutation interfered with crystallization. We conclude that the structural properties of PLB that govern the association of the monomer with the inhibitory site of SERCA are directly related to those used in the interaction of a PLB oligomer at the secondary, accessory site.
Effect of phosphorylation on physical interaction between SERCA and PLB
In studies of the PLB monomer, there is some consistent evidence that phosphorylation of Ser16 causes localized changes in the structure of its cytoplasmic domain. 32, 33, 35, 65, 66 These results provide a physical basis for disruption of the productive structural interaction between SERCA and PLB, which might lead to dissociation of the complex. Early NMR and CD spectroscopy studies showed a continuous α-helix in the N-terminal portion of PLB (residues 1-16), which partially unwound upon phosphorylation (residues 12-16 were no longer helical). 35 However, these studies utilized an N-terminal fragment of PLB (residues 1-25), rather than the full-length protein, and did not include SERCA. Since then, there have been many structural models for full-length PLB based on NMR measurements in the non-phosphorylated, 41, 61, [67] [68] [69] [70] [71] phosphorylated 65 and pseudo-phosphorylated 72 state under a variety of experimental conditions. These models differ in the amount of secondary structure in the N-terminal cytoplasmic domain of PLB, suggesting that this domain can adopt a variety of conformational states. Furthermore, most studies agree that phosphorylation alters the dynamics of this domain, the NMR structure of a pseudophosphorylated form of PLB notwithstanding. 72 A variety of biophysical studies indicate that PLB undergoes a conformational change upon phosphorylation. 12, 34, 35, 73 Many of these ideas coalesced in recent EPR 32 and NMR 33, 66 studies, which proposed an order-to-disorder transition in the cytoplasmic domain of PLB that disrupts intermolecular contacts and reverses SERCA inhibition, but does not dissociate the SERCA-PLB complex.
Consistent with this idea, we found that phosphorylation of wild type PLB at Ser16 selectively disordered the cytoplasmic domains of the pentamer (Fig. 1) and reduced its ability to mediate 2D crystallization with SERCA (Table 2 ). In maps from negatively stained crystals, density attributable to the cytoplasmic domain disappeared when PLB was phosphorylated, whereas maps from frozen-hydrated crystals showed that the transmembrane helices of PLB were still clearly visible. We conclude that the transmembrane domain of phosphorylated PLB remains associated with SERCA in the co-crystals, even though the cytoplasmic domain became disordered. This disordering did not occur for the K27A gain-of-function mutant (Fig. 2) but it did occur for the N34A loss-of-function mutant, even in the non-phosphorylated state (Fig. 4) . Furthermore, the propensity to induce co-crystallization was retained by the K27A mutant after phosphorylation, whereas the N34A mutant was marginal in cocrystallization, even in the non-phosphorylated state (Table 2) . It is interesting to consider where these three residues lie in the structure of PLB. Ser16 flanks the N-terminal end of domain Ib, Lys27 is found in the middle of this domain and Asn34 flanks the C-terminal end. These residues also have two opposed functional effects; PLB function is lost when phosphorylated at Ser16 or mutated at Asn34 and PLB function is enhanced when mutated at Lys27. Thus, domain Ib might be the key structural element responsible for phosphorylationor mutation-dependent conformational changes in the PLB cytoplasmic domain that impact SERCA inhibition. Indeed, many of the structural differences between existing PLB models involve domain Ib, 41, 61, 65, [67] [68] [69] [70] [71] [72] suggesting that this domain might be a less structured, more dynamic region of the protein. Therefore, it is reasonable to suppose that phosphorylation alters the dynamics of domain Ib, thereby controlling an order-todisorder transition in the PLB cytoplasmic domain and reversing SERCA inhibition. 29, 31, 32 Model for the interaction of the PLB pentamer
The major findings in this study are that the PLB pentamer is capable of a physical interaction with SERCA and that this interaction is sensitive to functional modification of PLB through phosphorylation or mutation. In particular, PKA-mediated phosphorylation of Ser16 caused the cytoplasmic domain of PLB to become disordered, yet the pentamer remained associated with SERCA through intramembrane interactions. This disordering occurred also for a well characterized loss-of-function mutation, Asn34Ala, suggesting that the loss of inhibition might occur through a molecular mechanism similar to phosphorylation. These data are consistent with a functional interaction between SERCA and PLB oligomers, 40 and inconsistent with the notion of PLB oligomers as inactive storage forms. 21 The inhibitory site involving the PLB monomer and transmembrane helices M2, M4 and M6 of SERCA 45, 48, 61 is distinct from the physical interactions that stabilize our 2D crystals, which center on M3 of SERCA and involve the transmembrane domain of PLB. The inhibitory site of SERCA alternately opens and closes during the calcium transport cycle, owing to large movements of transmembrane helices M2, M4 and M6. This is not the case for the accessory site of SERCA, because M3 is less mobile during the transport cycle. Thus, M3 could act as an interaction point between SERCA and the PLB pentamer (and perhaps other oligomeric forms). Interestingly, a primary structure comparison between SERCA and PLB reveals a region of potential sequence similarity that spans the C-terminal portion of the PLB transmembrane helix and M3 of SERCA (Fig. 8) . Residues Leu266, Val269 and Leu273 of SERCA face the lipid environment and transmembrane segment M3 of SERCA (residues 254-274). Leu44, Ile47 and Leu51 make up part of the leucine-isoleucine zipper that stabilizes the pentameric state of PLB. Lower: The pentamer and monomer are in dynamic equilibrium, where the monomer is postulated to interact with and inhibit SERCA (righthand side). We hypothesize that the pentamer also interacts with SERCA, which leads to the active association or dissociation of a monomer (left-hand side). The active dissociation of a monomer leads to a physical interaction with and inhibition of SERCA and this process is reversed by phosphorylation of PLB. These two pathways are not mutually exclusive and might operate simultaneously or under disparate physiological conditions. and adopt a side chain orientation similar to that of Leu44, Ile47 and Leu51 of PLB. These residues form part of the leucine-isoleucine zipper that stabilizes the pentameric form of PLB. 74 Through its interaction with M3 of SERCA, the PLB pentamer might play a more active role in capturing monomeric or phosphorylated PLB species. Specifically, this SERCA-pentamer interaction might facilitate the exchange of PLB monomers with the SERCA inhibitory site in response to physiological cues (elevated cytosolic calcium and/ or phosphorylation). This interaction would also explain how SERCA is able to influence the oligomeric state of PLB. 63 Based on their NMR structure of a PLB pentamer, Oxenoid and Chou suggested that individual PLB monomers could initiate binding to SERCA without dissociation from the pentamer. 41 We suggest a modification of this hypothesis, where a PLB pentamer interacts with the membrane domain of SERCA and serves as a reservoir for directed diffusion of monomers to and from the inhibitory site (Fig. 8) . This pathway might be important in efficiently delivering monomeric PLB to its binding site on SERCA, ensuring that the inhibited state is maintained following a cycle of calcium release in cardiac muscle. Specifically, a site for the PLB pentamer on SERCA might position the monomer in a conformation that is compatible with formation of the inhibitory complex, as suggested earlier. 41 Furthermore, the resultant depolymerization of the PLB pentamer would leave behind a tetramer that might remain associated with the pump. There is ample evidence of intermediate oligomeric states for PLB 50 and such intermediates could be poised to reacquire a PLB monomer once it dissociates from the inhibitory complex with SERCA. Finally, phosphorylation has been shown to increase the oligomeric propensity of PLB 16 and an interaction of these species with the pump could ensure a rapid return to the inhibited state upon dephosphorylation. Otherwise, if allowed to diffuse away during a period of β-adrenergic stimulation, there could be a substantial delay before SERCA randomly encounters a non-phosphorylated PLB molecule within the membrane plane.
Materials and Methods
Octaethylene glycol monododecyl ether (C 12 E 8 ) was obtained from Barnet Products (Englewood Cliff, NJ). SM-2 Biobeads were obtained from Bio-Rad (Hercules, CA). Egg yolk phosphatidylcholine (EYPC), egg yolk phosphatidylethanolamine (EYPE) and egg yolk phosphatidic acid (EYPA) were obtained from Avanti Polar Lipids (Alabaster, AL). All reagents used in the coupled enzyme assay for measuring ATPase activity were of the highest purity available (Sigma-Aldrich, Oakville, ON Canada). 75 Reconstitution of SERCA with PLB SERCA was prepared from rabbit hind leg muscle 76 by affinity chromatography. 9 Recombinant human PLB was prepared as described. 77 The following proteins were used in this study: wild type PLB, a gain-of-function mutant Lys27Ala (K27A), a partial loss-of-function mutant Arg14Ala (R14A), and a loss-of-function mutant Asn34Ala (N34A). Coreconstitution of SERCA with PLB followed established methods for the formation of large 2D co-crystals. 42 Briefly, 100 μg of PLB and 600 μg of lipids (EYPC/EYPE/ EYPA in a weight ratio of 8:1:1) were solubilized in a chloroformtrifluoroethanol mixture, dried to a thin film under nitrogen gas and lyophilized. Buffer (20 mM imidazole, pH 7.0, 100 mM KCl, 0.02% (w/v) NaN 3 ) and detergent (C 12 E 8 ) were added to solubilize the mixture, followed by the addition of 500 μg of detergent-solubilized, purified SERCA. It has been shown that this method of co-reconstitution yields complete recovery of SERCA transport activity and PLB inhibition. 50, 78 The final concentrations were adjusted to a 1:1:2 weight ratio of protein/lipid/detergents (final molar ratio of SERCA/ PLB/lipids of approximately1:3.5:180). The detergent was removed by the slow addition of SM-2 Biobeads (25 mg of wet beads) over 4 h. For the best results, crystallization was performed immediately on the co-reconstituted proteoliposomes containing SERCA and PLB. Reconstituted proteoliposomes containing SERCA in the absence of PLB were prepared simultaneously under identical conditions. ATPase activity of the proteoliposomes was measured by a coupledenzyme assay over a range of calcium concentrations of 0.1 μM-10 μM. 51, 75 The apparent calcium affinity, K ca , was determined by fitting the data to the Hill equation using Sigma Plot software (SPSS Inc., Chicago, IL). The functional characterization of these mutants has been described by others 17, 55 as well as by our laboratory. 51 For studies of the effect of PLB phosphorylation, wild type and K27A PLB were solubilized in detergent and phosphorylated with the catalytic subunit of PKA; Sigma-Aldrich, St. Louis, MO) before co-reconstitution with SERCA into proteoliposomes. PKA was added to a concentration of 100 units/mg of detergent-solubilized PLB and the reaction was incubated at 30°C for 3 h. It was concluded that this treatment resulted in complete phosphorylation of PLB, because the unphosphorylated protein could not be detected either by MALDI-TOF mass spectrometry or by SDS-PAGE and western blotting (data not shown).
2D crystallization
Co-reconstituted proteoliposomes were collected by centrifugation in crystallization buffer (20 mM imidazole, pH 7.4, 100 mM KCl, 35 mM MgCl 2 , 0.5 mM EGTA, 0.25 mM Na 3 VO 4 , 30 μM thapsigargin). 79 The pellet was subjected to two freeze-thaw cycles, suspended with a micropipette, followed by two more freeze-thaw cycles. Reconstituted samples were incubated at 4°C for up to one week. Although crystallization occurred quickly, three to five days was optimal for the highest frequency and quality of 2D crystals.
Electron microscopy
Crystals were imaged in a Tecnai F20 electron microscope (FEI Company, Einhoven, Netherlands) in the Microscopy and Imaging Facility (University of Calgary) or a JEOL 2200FS electron microscope (JEOL Ltd., Tokyo, Japan) in the Electron Microscopy Facility (National Institute for Nanotechnology, University of Alberta and National Research Council of Canada). Both microscopes were operated at 200 kV. A standard room temperature holder was used for negatively stained samples and a Gatan 626 cryoholder (Gatan Inc., Pleasanton, CA) was used for frozen-hydrated samples. Low-dose images were recorded either on film at a magnification of 50,000× (Tecnai F20) or image plates at a magnification of 35,800× (JEOL 2200FS). For film, the best images were digitized at 6.35 μm/pixel with a Nikon Super Coolscan 9000 followed by pixel averaging to achieve a final resolution of 2.54 Å/ pixel. The image plates were scanned at 15 μmpixel for a final resolution of 4.44 Å/pixel. All data were recorded with defocus levels of 0.5-2 μm, with an emphasis on lowdefocus images (0.5 μm and 1 μm) for the frozen-hydrated samples.
Projection maps were determined using the MRC image processing suite. 80 Two rounds of lattice unbending were done before extracting amplitudes and phases from each image. Data from frozen-hydrated crystals were corrected for the contrast transfer function after estimating defocus levels using the program PLTCTFX. 81 Data from negatively stained crystals were not corrected for the contrast transfer function. Common phase origins for merging were determined in the p22 1 2 1 plane group using the program ORIGTILT (considering reflections with signal-tonoise ratio (IQ) b4). For averaging, data were weighted according to the IQ including data with IQ b7, and the corresponding phase residuals represent the inverse cosine of the figure of merit from this averaging. Projection maps were determined by Fourier synthesis from the averaged data using the CCP4 software suite, 82 followed by normalization of density levels to enable comparison of projection maps originating from different SERCA-PLB samples.
